HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAD1. A total of 64 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,127 | +1.6% | 44 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $36,545 | -2.0% | 44 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $37,290 | -12.5% | 44 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $42,597 | -99.9% | 44 | -99.9% | 0.00% | 0.0% |
| Q3 2022 | $37,235,000 | -4.1% | 44,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $38,815,000 | – | 44,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 71,432 | $63,617,000 | 4.32% |
| Western Asset Management Company, LLC | 15,600,000 | $13,690,000 | 4.04% |
| CAMDEN ASSET MANAGEMENT L P /CA | 70,849,000 | $61,727,000 | 1.84% |
| ZAZOVE ASSOCIATES LLC | 16,992,000 | $14,985,000 | 1.32% |
| Penn Mutual Asset Management, LLC | 1,305,000 | $1,137,000 | 1.32% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 64,750,000 | $56,413,000 | 0.72% |
| CQS (US), LLC | 10,000,000 | $8,777,000 | 0.61% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 28,859,000 | $25,319,000 | 0.40% |
| Context Capital Management, LLC | 4,122 | $3,632,000 | 0.24% |
| Hudson Bay Capital Management LP | 19,500,000 | $17,152,000 | 0.23% |